| Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy W Choi, S Porten, S Kim, D Willis, ER Plimack, J Hoffman-Censits, B Roth, ... Cancer cell 25 (2), 152-165, 2014 | 1638 | 2014 |
| Bladder cancer AM Kamat, NM Hahn, JA Efstathiou, SP Lerner, PU Malmström, W Choi, ... The Lancet 388 (10061), 2796-2810, 2016 | 1243 | 2016 |
| Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer T Arumugam, V Ramachandran, KF Fournier, H Wang, L Marquis, ... Cancer research 69 (14), 5820-5828, 2009 | 1008 | 2009 |
| A consensus molecular classification of muscle-invasive bladder cancer A Kamoun, A de Reyniès, Y Allory, G Sjödahl, AG Robertson, R Seiler, ... European urology 77 (4), 420-433, 2020 | 927 | 2020 |
| Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ... European urology 72 (4), 544-554, 2017 | 753 | 2017 |
| miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy L Adam, M Zhong, W Choi, W Qi, M Nicoloso, A Arora, G Calin, H Wang, ... Clinical cancer research 15 (16), 5060-5072, 2009 | 526 | 2009 |
| Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer DJ McConkey, W Choi, L Marquis, F Martin, MB Williams, J Shah, ... Cancer and Metastasis Reviews 28, 335-344, 2009 | 424 | 2009 |
| ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma MP Kim, JB Fleming, H Wang, JL Abbruzzese, W Choi, S Kopetz, ... PloS one 6 (6), e20636, 2011 | 323 | 2011 |
| Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer W Choi, B Czerniak, A Ochoa, X Su, A Siefker-Radtke, C Dinney, ... Nature Reviews Urology 11 (7), 400-410, 2014 | 319 | 2014 |
| A prognostic gene expression signature in the molecular classification of chemotherapy-naive urothelial cancer is predictive of clinical outcomes from neoadjuvant chemotherapy … DJ McConkey, W Choi, YU Shen, IL Lee, S Porten, SF Matin, AM Kamat, ... European urology 69 (5), 855-862, 2016 | 273 | 2016 |
| Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression DJ McConkey, S Lee, W Choi, M Tran, T Majewski, S Lee, ... Urologic Oncology: Seminars and Original Investigations 28 (4), 429-440, 2010 | 261 | 2010 |
| Genetic alterations in the molecular subtypes of bladder cancer: illustration in the cancer genome atlas dataset W Choi, A Ochoa, DJ McConkey, M Aine, M Höglund, WY Kim, FX Real, ... European urology 72 (3), 354-365, 2017 | 205 | 2017 |
| The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205 MN Tran, W Choi, MF Wszolek, N Navai, ILC Lee, G Nitti, S Wen, ... Journal of Biological Chemistry 288 (5), 3275-3288, 2013 | 164 | 2013 |
| Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer S Claerhout, JY Lim, W Choi, YY Park, KH Kim, SB Kim, JS Lee, GB Mills, ... PloS one 6 (9), e24662, 2011 | 151 | 2011 |
| Molecular subtypes of bladder cancer DJ McConkey, W Choi Current oncology reports 20, 1-7, 2018 | 150 | 2018 |
| Gene expression profile of the clinically aggressive micropapillary variant of bladder cancer CC Guo, V Dadhania, LI Zhang, T Majewski, J Bondaruk, M Sykulski, ... European urology 70 (4), 611-620, 2016 | 139 | 2016 |
| Adaptive immune resistance to intravesical BCG in non–muscle invasive bladder cancer: Implications for prospective BCG-unresponsive trials M Kates, A Matoso, W Choi, AS Baras, MJ Daniels, K Lombardo, A Brant, ... Clinical cancer research 26 (4), 882-891, 2020 | 119 | 2020 |
| Assessment of luminal and basal phenotypes in bladder cancer CC Guo, J Bondaruk, H Yao, Z Wang, L Zhang, S Lee, JG Lee, D Cogdell, ... Scientific reports 10 (1), 9743, 2020 | 109 | 2020 |
| p63 expression defines a lethal subset of muscle-invasive bladder cancers W Choi, JB Shah, M Tran, R Svatek, L Marquis, IL Lee, D Yu, L Adam, ... PloS one 7 (1), e30206, 2012 | 103 | 2012 |
| Fibroblast growth factor receptors-1 and-3 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting T Cheng, B Roth, W Choi, PC Black, C Dinney, DJ McConkey PloS one 8 (2), e57284, 2013 | 102 | 2013 |
